In the last trading session, 1.35 million shares of the Kura Oncology Inc. (NASDAQ:KURA) were traded, and its beta was 0.84. Most recently the company’s share price was $13.93, and it changed around $0.54 or 4.03% from the last close, which brings the market valuation of the company to $914.09M. KURA currently trades at a discount to its 52-week high of $19.93, offering almost -43.07% off that amount. The share price’s 52-week low was $9.49, which indicates that the current value has risen by an impressive 31.87% since then. We note from Kura Oncology Inc.’s average daily trading volume that its 10-day average is 0.68 million shares, with the 3-month average coming to 609.24K.
Kura Oncology Inc. stock received a consensus recommendation rating of a Buy, based on a mean score of 1.60. If we narrow it down even further, the data shows that 0 out of 12 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended KURA as a Hold, whereas 11 deemed it a Buy, and 0 rated it as Underweight. Kura Oncology Inc. is expected to report earnings per share of -$0.56 for the current quarter.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Kura Oncology Inc. (NASDAQ:KURA) trade information
Instantly KURA has showed a green trend with a performance of 4.03% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 14.32 on Tuesday, 05/23/23 increased the stock’s daily price by 2.72%. The company’s shares are currently up 12.25% year-to-date, but still up 11.26% over the last five days. On the other hand, Kura Oncology Inc. (NASDAQ:KURA) is 29.46% up in the 30-day period. We can see from the shorts that 7.88 million shares have been sold at a short interest cover period of 13.27 day(s).
The consensus price target as assigned by Wall Street analysts is $31.64, which translates to bulls needing to increase their stock price by 55.97% from its current value. Analyst projections state that KURA is forecast to be at a low of $22.00 and a high of $47.00. In order for the stock price to hit the forecast high, the stock would need to plunge -237.4% from its current level, while the stock would need to crash -57.93% from its current level to reach the projected low.
Kura Oncology Inc. (KURA) estimates and forecasts
Kura Oncology Inc. share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -7.69 percent over the past six months and at a -14.78% annual growth rate that is well below the industry average of 11.20%. Moreover, analysts have decided to roll up on their fiscal year 2023 revenue estimates. The rating firms predict that it will loss -7.70% in revenue this quarter, and will report a decrease of -15.10% in the next quarter.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -5.90%. Kura Oncology Inc. earnings are expected to increase by -3.10% in 2023, but the outlook is positive 19.93% per year for the next five years.
KURA Dividends
Kura Oncology Inc.’s next quarterly earnings report is expected to be released around August 01 and August 07.
Kura Oncology Inc. (NASDAQ:KURA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.94% of Kura Oncology Inc. shares, and 106.44% of them are in the hands of institutional investors. The stock currently has a share float of 108.54%. Kura Oncology Inc. stock is held by 225 institutions, with BVF Inc. being the largest institutional investor. By Mar 30, 2023, it held 9.84% of the shares, which is about 6.73 million shares worth $82.32 million.
EcoR1 Capital, LLC, with 9.70% or 6.64 million shares worth $81.19 million as of Mar 30, 2023, holds the second largest percentage of outstanding shares.
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Feb 27, 2023. The former held 2.78 million shares worth $33.15 million, making up 4.06% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 1.97 million shares worth around $24.44 million, which represents about 2.88% of the total shares outstanding.
